“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...

The label expansion sought by GSK is a bid to compete with Pfizer and Moderna in the younger age groups of the RSV vaccine market. Pfizer’s Abrysvo and Moderna’s mRESVIA are both approved to prevent ...

FDA accepts GSK's filing to extend Arexvy's RSV vaccine use to high-risk adults under 50, with a decision due in 2026.

One major reason why the U.S. and Western Europe have seen dramatic population increase over the last 200-plus years, Aaby ...

Kennedy selected a new team of medical professionals and scientists who are highly qualified and dedicated to public health.

The update covers the safety and appropriate timing of vaccinations, screening for osteoporosis, cervical cancer, skin cancer ...

The American College of Obstetricians and Gynecologists (ACOG) plans to develop and release recommendations on maternal immunizations, including COVID-19 vaccination, alongside the Center for ...

Moderna stock has faced heavy pressure from negative headlines, regulatory setbacks and political uncertainty. See why I ...

Six in 10 U.S. adults think that AI-generated health information is somewhat or very reliable, a survey from the Annenberg Public Policy Center finds. But nearly half (49%) are not comfortable with ...

If I have sounded like a broken record these past months, it is because these developments in American public health are as ...